Therapy for Relapsed and Refractory Pediatric Hodgkin Lymphoma

R Chopra, AK McMillan, DC Linch, S Yuklea, G Taghipour, R Pearce, KG Patterson, AH Goldstone, The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. Blood. ,vol. 81, pp. 1137- 1145 ,(1993) , 10.1182/BLOOD.V81.5.1137.1137

Andreas Josting, Ulrich Rueffer, Jeremy Franklin, Markus Sieber, Volker Diehl, Andreas Engert, Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group. Blood. ,vol. 96, pp. 1280- 1286 ,(2000) , 10.1182/BLOOD.V96.4.1280

By Hillard M. Lazarus, Philip A. Rowlings, Mei-Jie Zhang, Julie M. Vose, James O. Armitage, Philip J. Bierman, James L. Gajewski, Robert Peter Gale, Arm Keating, John P. Klein, Carole B. Miller, Gordon L. Phillips, Donna E. Reece, Kathleen A. Sobocinski, Koen van Besien, Mary M. Horowitz, Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the autologous blood and marrow transplant registry Journal of Clinical Oncology. ,vol. 17, pp. 534- 545 ,(1999) , 10.1200/JCO.1999.17.2.534

D L Longo, P L Duffey, R C Young, S M Hubbard, D C Ihde, E Glatstein, J C Phares, E S Jaffe, W J Urba, V T DeVita, Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. Journal of Clinical Oncology. ,vol. 10, pp. 210- 218 ,(1992) , 10.1200/JCO.1992.10.2.210

Marc André, Michel Henry-Amar, José-Luis Pico, Pauline Brice, Didier Blaise, Mathieu Kuentz, Bertr Coiffier, Philippe Colombat, Jean-Yves Cahn, Michel Attal, Joël Fleury, Noël Milpied, Gérard Nedellec, Pierre Biron, Hervé Tilly, Jean-Paul Jouet, Christian Gisselbrecht for the Société Franca, Comparison of High-Dose Therapy and Autologous Stem-Cell Transplantation With Conventional Therapy for Hodgkin's Disease Induction Failure: A Case-Control Study Journal of Clinical Oncology. ,vol. 17, pp. 222- 222 ,(1999) , 10.1200/JCO.1999.17.1.222

V Bonfante, A Santoro, S Viviani, L Devizzi, M Balzarotti, F Soncini, M Zanini, P Valagussa, G Bonadonna, Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. Journal of Clinical Oncology. ,vol. 15, pp. 528- 534 ,(1997) , 10.1200/JCO.1997.15.2.528

Anas Younes, Jorge Romaguera, Frederick Hagemeister, Peter McLaughlin, Maria Alma Rodriguez, Paolo Fiumara, Andre Goy, Sima Jeha, John T. Manning, Dan Jones, Lynne V. Abruzzo, L. Jeffrey Medeiros, A pilot study of rituximab in patients with recurrent, classic Hodgkin disease. Cancer. ,vol. 98, pp. 310- 314 ,(2003) , 10.1002/CNCR.11511

Sonali M. Smith, Koen van Besien, Jeanette Carreras, Asad Bashey, Mitchell S. Cairo, Cesar O. Freytes, Robert Peter Gale, Gregory A. Hale, Brandon Hayes-Lattin, Leona A. Holmberg, Armand Keating, Richard T. Maziarz, Philip L. McCarthy, Willis H. Navarro, Santiago Pavlovsky, Harry C. Schouten, Matthew Seftel, Peter H. Wiernik, Julie M. Vose, Hillard M. Lazarus, Parameswaran Hari, Second Autologous Stem Cell Transplantation for Relapsed Lymphoma after a Prior Autologous Transplant Biology of Blood and Marrow Transplantation. ,vol. 14, pp. 904- 912 ,(2008) , 10.1016/J.BBMT.2008.05.021

EP Alessandrino, Paolo Bernasconi, A Colombo, D Caldera, G Martinelli, P Vitulo, Luca Malcovati, C Nascimbene, M Varettoni, E Volpini, C Klersy, C Bernasconi, None, Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies. Bone Marrow Transplantation. ,vol. 25, pp. 309- 313 ,(2000) , 10.1038/SJ.BMT.1702154

Karl S Peggs, Anna Sureda, Wendi Qian, Dolores Caballero, Ann Hunter, Alvaro Urbano‐Ispizua, James Cavet, Josep M Ribera, Anne Parker, Miguel Canales, Premini Mahendra, Javier Garcia‐Conde, Donald Milligan, Guillermo Sanz, Kirsty Thomson, Reyes Arranz, Anthony H Goldstone, Ivan Alvarez, David C Linch, Jorge Sierra, Stephen Mackinnon, UK and Spanish Collaborative Groups, None, Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes British Journal of Haematology. ,vol. 139, pp. 70- 80 ,(2007) , 10.1111/J.1365-2141.2007.06759.X